TG Therapeutics, Inc.
corporate_fare Company Profile
TG Therapeutics, Inc. (NASDAQ:TGTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for TGTX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- TG Therapeutics Secures $500M Non-Dilutive Capital, Boosts Share Buyback to $300M
- BRIUMVI Post-Hoc Analysis Reveals Significant Efficacy in Highly Active MS Patients
- TG Therapeutics Reports Record 2025 Revenue & Net Income, Driven by BRIUMVI Sales and Significant Tax Benefit
- TG Therapeutics Reports Strong 2025 Results, Raises 2026 Revenue Guidance to $875-$900M, and Authorizes New $100M Buyback
- TG Therapeutics Reports Strong 2025 BRIUMVI Revenue, Issues Bullish 2026 Guidance, and Outlines Key Pipeline Milestones
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$616.29M
Net Income
$447.18M
Diluted EPS
$2.77
Op. Cash Flow
-$24.77M
Free Cash Flow
-$24.99M
Gross Profit
$515.57M
Operating Income
$123.32M
Cash & Equivalents
$79.15M
Total Debt
$245.65M
Debt / Equity
0.38×
Net Margin
72.6%
Shares Outstanding
155.31M sh
Source: 10-K · filed 2026-02-27 · accession 0001437749-26-006133
show_chartPrice Chart
Loading chart...
feed TGTX - Filings & News (Page 2)
TGTX
Mar 19, 2026, 7:30 AM EDT
Price at Filing:
$30.18
Real-time Price:
$63.21
Change:
+$33.03 (+109%)
Market Cap:
$9.574B
TGTX
Mar 09, 2026, 7:30 AM EDT
Price at Filing:
$28.50
Real-time Price:
$63.21
Change:
+$34.71 (+122%)
Market Cap:
$9.574B
TGTX
Feb 27, 2026, 5:05 PM EST
Price at Filing:
$29.70
Real-time Price:
$63.21
Change:
+$33.51 (+113%)
Market Cap:
$9.574B
TGTX
Feb 26, 2026, 7:08 AM EST
Price at Filing:
$27.61
Real-time Price:
$63.21
Change:
+$35.60 (+129%)
Market Cap:
$9.574B
TGTX
Jan 13, 2026, 4:27 PM EST
Price at Filing:
$29.82
Real-time Price:
$63.21
Change:
+$33.39 (+112%)
Market Cap:
$9.574B